Home » Newsletters » BioWorld

BioWorld

Nov. 5, 2001

View Archived Issues

Appointments And Advancements

Select, Cytomatrix End Venture, Scrap Plans For Their Merger

Correction

Other News To Note

ICOS Could Gross About $247M From Public Offering Of Shares

Two Inherited Sun-Sensitive Ills Likely Develop In Womb Before Postnatal Solar Ultraviolet Rays

Gliatech, Abgenix In Properdin Antibody Deal For Up To $40M

BioMarin, Genzyme Plan Filing Following Phase III MPS I Trial